Hudson Bay Capital Management
EVMN

Hudson Bay Capital Management’s Evommune Inc EVMN Stock Holding History

Hudson Bay Capital Management’s Portfolio EVMN Stock Details EVMN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-51,364
Closed -$1.18M – 1808
2026
Q1 		$1.18M Buy
+51,364
New +$1.16M ﹤0.01% 855

Other funds holding EVMN

EFM
EQT Fund Management Luxembourg $863M AUM 26.03% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $308M AUM 120.89% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
NFGH
Nan Fung Group Holdings Kai Tak, Hong Kong $131M AUM 86.64% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
AP
Andera Partners Paris $206M AUM
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Hudson Bay Capital Management's EVMN Position: Q2 2026 in Review

Hudson Bay Capital Management sold out of Evommune Inc (EVMN) in Q2 2026, closing a stake of 51,364 shares — an estimated $1.18M sold.

Hudson Bay Capital Management first reported a position in EVMN in Q1 2026 and held it in 1 quarter. The position peaked at $1.18M in Q1 2026. 105 funds tracked by Wall St. Rank hold EVMN as of Q2 2026.

  • Hudson Bay Capital Management reported no remaining Evommune Inc position as of Q2 2026 after selling out during the quarter.
  • Hudson Bay Capital Management sold 51,364 Evommune Inc shares in Q2 2026, an estimated $1.18M.
  • Hudson Bay Capital Management first reported a position in Evommune Inc in Q1 2026 and held it in 1 quarter.
  • Hudson Bay Capital Management's Evommune Inc position peaked at $1.18M in Q1 2026.
  • 105 funds tracked by Wall St. Rank held Evommune Inc as of Q2 2026.

Based on Hudson Bay Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.